Cartesian Therapeutics, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Cartesian Therapeutics, Inc. Share Price Chart

$0.00$0.00

Cartesian Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $-5.02	Revenue (TTM) $400000.00	Return On Equity (TTM) 103.22%
Profit Margin -32575.50%	Debt to Equity -0.12	Quarterly Earnings Growth YoY N/A

About Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.

Cartesian Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %

RNAC Share Price FAQs

What is Cartesian Therapeutics, Inc. share price today?

Cartesian Therapeutics, Inc. share price today is $0.00 as on August 9, 2026 at 2:11 pm IST.

What is the 52 week high and 52 week low of Cartesian Therapeutics, Inc. stock?

52 week high/low data for Cartesian Therapeutics, Inc. is currently unavailable.

Can I buy RNAC shares in India?

Yes. You can buy RNAC in India by opening an international trading account.